Thursday, November 21, 2019
Home Authors Posts by Editor / Curator

Editor / Curator

150 POSTS 0 COMMENTS
biotech stock review
Biotech News

Innovus (INNV) Gains 75% in Past Week.

Editor / Curator -
aytu, innovus
Internet News

AYTU (ATYU) ‘Team’ Letter on Innovus (INNV) Acquisition.

Editor / Curator -
Institutional Analyst Newsletter

Adding Accelerize (ACLZ) $0.05 to Watch List.

Editor / Curator -
Lindsay Rosenwald, Biotech Stock Review
Biotech News

Newsworthy: Fortress Bio (FBIO) $1.73, Gets $20 Price Target!

Editor / Curator -
Biotech News

Cougar Biotechnology. A $500,000 Investment Acquired for $1 Billion.

Editor / Curator -
News

SEC Charges TherapeuticsMD (TXMD) $2.80 With Regulation FD Violations

Editor / Curator -
Mustang Bio
Biotech News

Mustang Bio (MBIO) Investor Presentation

Editor / Curator -
Institutional Analyst Newsletter

Don’t Under Promise and Over Deliver. Just Deliver!

Editor / Curator -
Biotech News

Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase...

Editor / Curator -
eCommerce

MySize (MYSZ) in Jerusalem Post.

Editor / Curator -
1234...15Page 3 of 15

Latest article

biogen, biotech stock review

Biotech’s Turning Up…

Biotech News Editor / Curator -
Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News. We keep telling investors...
True Nature, Biotech Stock Review

True Nature | Mitesco (TNTY), Perking Up.

Accelerator Editor / Curator -
Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...
Dyadic, Biotech Stock Review

Dyadic (DYAI) Highlights.

Biotech News Editor / Curator -
"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.